Humanigen announced COVID-19 case report demonstrated rapid resolution after single IND EUA of Lenzilumabル
On Oct. 2, 2020, Humanigen announced that a patient case report on the use of lenzilumabル in critical…
On Oct. 2, 2020, Humanigen announced that a patient case report on the use of lenzilumabル in critical…
On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) (OVPR) announced a new…
On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…
On Oct. 1, 2020, american hospitals began purchasing Veklury (remdesivir) directly from the drugメs distributor. Veklury is an…
On Oct. 1, 2020, Gilead Sciences announced that it will be responsible for distributing Veklury in the U.S….
On Sept. 30, 2020, the NIH announced that it had awarded nearly $234 million to improve COVID-19 testing…
On Sept. 30, 2020, University of Oxford researchers announced they had begun a new study to explore the…
On Sept. 30, 2020, the National Science Foundation (NSF) announced that it had funded more than 80 startups…
On Sept. 30, 2020, the United Nations and its partners announced that nearly $1 billion in financing was…
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
On Sept. 29, 2020, a further collaboration among the Serum Institute of India (SII), Gavi and the Bill…
On Sept. 29, 2020, Regeneron announced the first data from a descriptive analysis of a seamless Phase 1/2/3…
On Sept. 29, 2020, Windtree Therapeutics announced that FDA had accepted its Investigational New Drug application for a…
On Sept. 29, 2020, CureVac announced that the first participant has been dosed in a Phase 2a clinical…
On Sept. 29, 2020, the CDC reported that during Aug. 2ヨSept. 5, 2020, weekly COVID-19 cases among persons…
On Sept. 29, 2020, the NIH announed that researchers had designed モminiproteinsヤ that bound tightly to the SARS-CoV-2…
On Sept. 28, 2020, Eiger BioPharmaceuticals announced results of an investigator sponsored study of Peginterferon Lambda-1a (Lambda) in…
On Sept. 28, 2020, the U.S. Departments of Defense and Health and Human Services signed a $20 million…
On Sept. 28 2020, ViroVax announced that it had licensed its adjuvant, Alhydroxiquim-II, to Bharat Biotech International, an…
On Sept. 28, 2020, a genetic study identified neuronal abnormalities in the electrical activity of cortical cells derived…
On Sept. 28, 2020, in an article published in Nature Genetics, researchers confirmed that about 14% of all…
On Sept. 28, 2020, as COVID-19 infections began to rise again, a novel testing strategy was proposed by…
On Sept. 28, 2020, Hologic announced that its Panther Fusionᆴ SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
On Sept. 28, 2020, OpGen announced the successful completion of the clinical study between its subsidiary, Curetis, and…
On Sept. 28, 2020, Immunic announced the results of a pre-planned interim safety analysis and a recruitment update…
On Sept. 25, 2020, scientists from the University of Oxfordメs Nuffield Department of Medicine published their evaluation of…
On Sept. 25, 2020, the Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination with a quadrivalent meningococcal…
On Sept. 24, 2020, new findings reported by scientists at the National Institutes of Health and their collaborators…
On Sept. 24, 2020, a team of scientists announced they had created the first atlas of human heart…
On Sept. 24, 2020, the U.S. Department of Health and Human Services and the U.S. Food and Drug…